1-8 of 8
antigens, cd98 light chains
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IGVL gene region usage correlates with distinct clinical presentation in IgM vs non-IgM light chain amyloidosis

Clinical Trials & Observations
Surbhi Sidana, Surendra Dasari, Taxiarchis V. Kourelis, Angela Dispenzieri, David L. Murray, Rebecca L. King, Ellen D. McPhail, Marina Ramirez-Alvarado, Shaji K. Kumar, Morie A. Gertz
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2101–2105.
https://doi.org/10.1182/bloodadvances.2020003671
Published: 2021
Includes: Supplemental data
Journal Articles

Pharmacologic targeting of plasma cell endoplasmic reticulum proteostasis to reduce amyloidogenic light chain secretion

Bibiana Rius, Jaleh S. Mesgarzadeh, Isabelle C. Romine, Ryan J. Paxman, Jeffery W. Kelly, R. Luke Wiseman
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1037–1049.
https://doi.org/10.1182/bloodadvances.2020002813
Published: 2021
Includes: Supplemental data
Journal Articles

Prognostic restaging after treatment initiation in patients with AL amyloidosis

Clinical Trials & Observations
Nadine Abdallah, Angela Dispenzieri, Eli Muchtar, Francis K. Buadi, Prashant Kapoor, Martha Q. Lacy, Yi L. Hwa, Amie Fonder, Miriam A. Hobbs, Suzanne R. Hayman, Nelson Leung, David Dingli, John A. Lust, Ronald S. Go, Yi Lin, Wilson I. Gonsalves, Taxiarchis Kourelis, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz, Shaji K. Kumar
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1029–1036.
https://doi.org/10.1182/bloodadvances.2020003782
Published: 2021
Journal Articles

Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis

Clinical Trials & Observations
Marco Basset, Paolo Milani, Mario Nuvolone, Francesca Benigna, Lara Rodigari, Andrea Foli, Giampaolo Merlini, Giovanni Palladini
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4175–4179.
https://doi.org/10.1182/bloodadvances.2020002219
Published: 2020
Includes: Supplemental data
Journal Articles

CAR T-cell therapy: is it prime time in myeloma?

Surbhi Sidana, Nina Shah
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3473–3480.
https://doi.org/10.1182/bloodadvances.2019000370
Published: 2019
Journal Articles

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Nidhi Tandon, Surbhi Sidana, S. Vincent Rajkumar, Morie A. Gertz, Francis K. Buadi, Martha Q. Lacy, Prashant Kapoor, Wilson I. Gonsalves, Angela Dispenzieri, Taxiarchis V. Kourelis, Rahma Warsame, David Dingli, Amie L. Fonder, Suzanne R. Hayman, Miriam A. Hobbs, Yi Lisa Hwa, Robert A. Kyle, Nelson Leung, Ronald S. Go, John A. Lust, Stephen J. Russell, Shaji K. Kumar
Journal: Blood Advances
Blood Adv (2019) 3 (5): 744–750.
https://doi.org/10.1182/bloodadvances.2018022806
Published: 2019
Journal Articles

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

Clinical Trials & Observations
M Hasib Sidiqi, Mohammed A. Aljama, Eli Muchtar, Francis K. Buadi, Rahma Warsame, Martha Q. Lacy, Angela Dispenzieri, David Dingli, Nelson Leung, Wilson I. Gonsalves, Shaji K. Kumar, Prashant Kapoor, Taxiarchis V. Kourelis, William J. Hogan, Morie A. Gertz
Journal: Blood Advances
Blood Adv (2018) 2 (7): 769–776.
https://doi.org/10.1182/bloodadvances.2018016782
Published: 2018
Includes: Supplemental data
Journal Articles

Activated protein C light chain provides an extended binding surface for its anticoagulant cofactor, protein S

José A. Fernández, Xiao Xu, Ranjeet K. Sinha, Laurent O. Mosnier, Michel F. Sanner, John H. Griffin
Journal: Blood Advances
Blood Adv (2017) 1 (18): 1423–1426.
https://doi.org/10.1182/bloodadvances.2017007005
Published: 2017
Includes: Supplemental data